CIBA-GEIGY ACCUTRIM USE OF ALZA's OROS TIMED-RELEASE SYSTEM MAKES PRODUCT A NEW DRUG BECAUSE OF "NEW AND UNIQUE" MECHANISM, FDA TELLS FIRM

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".